CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, reported financial results for the fourth quarter and full year ended December 31, 2020.
February 24, 2021
· 13 min read